ERBB2 and neoplasm: The gastric lesion demonstrated a wild-type ERBB2 (Fig. 2B and Table 1), high tumor mutation burden (TMB-H, 35.67 mutation/Mb), MSI-H, and PD-L1 negativity (tumor cell proportion score = 0%, combined positive score < 1, Fig. 2C).